Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02975245 · ClinicalTrials.gov registry record
Short Term Genetic Effects of Chemotherapy on Male Germ Cells
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 200
- Enrollment target
NCT02975245: Completed study, sponsored by University of Pittsburgh.
NCT02975245 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02975245 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This study will determine the short-term effects of chemotherapy on sperm DNA.The study involves the collection of semen sample through ejaculation prior to initiation of chemotherapy and up to three time points after initiation of chemotherapy.
Primary Outcome
Sperm count test analyzes the health and viability of sperm, as it takes into account sperm number, motility, and morphology.
Interventions
- PROCEDURE Semen collection and analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-02 |
| Est. Completion | 2025-04 |
What the finished NCT02975245 record still lists
NCT02975245 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Semen collection and analysis is the first listed.
NCT02975245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02975245 about?
NCT02975245 is a clinical study titled "Short Term Genetic Effects of Chemotherapy on Male Germ Cells". This study will determine the short-term effects of chemotherapy on sperm DNA.The study involves the collection of semen sample through ejaculation prior to initiation of chemotherapy and up to three time points after initiation of chemotherapy.
What is the current status of trial NCT02975245?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2013-02. Estimated completion is 2025-04.
What interventions are being tested in trial NCT02975245?
The interventions under investigation include: Semen collection and analysis (PROCEDURE).
Who is sponsoring clinical trial NCT02975245?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia